Success Metrics

Clinical Success Rate
90.6%

Based on 29 completed trials

Completion Rate
91%(29/32)
Active Trials
11(19%)
Results Posted
7%(2 trials)
Terminated
3(5%)

Phase Distribution

Ph not_applicable
25
44%
Ph phase_1
1
2%
Ph phase_2
1
2%
Ph phase_4
1
2%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution28 total trials
Phase 1Safety & dosage
1(3.6%)
Phase 2Efficacy & side effects
1(3.6%)
Phase 4Post-market surveillance
1(3.6%)
N/ANon-phased studies
25(89.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.3%

29 of 34 finished

Non-Completion Rate

14.7%

5 ended early

Currently Active

11

trials recruiting

Total Trials

57

all time

Status Distribution
Active(15)
Completed(29)
Terminated(5)
Other(8)

Detailed Status

Completed29
unknown8
Recruiting7
Active, not recruiting4
Terminated3
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
57
Active
11
Success Rate
90.6%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (3.6%)
Phase 21 (3.6%)
Phase 41 (3.6%)
N/A25 (89.3%)

Trials by Status

terminated35%
withdrawn24%
recruiting712%
active_not_recruiting47%
completed2951%
unknown814%
enrolling_by_invitation12%
not_yet_recruiting35%

Recent Activity

Clinical Trials (57)

Showing 20 of 57 trialsScroll for more
NCT07143669

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Recruiting
NCT00201266

Histoblood Group Antigens as a Risk Factor of Asthma

Completed
NCT05476588Not Applicable

Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform

Completed
NCT05772221Not Applicable

The Role of Social Determinants in Cardiovascular Health and Vascular Function

Completed
NCT06736106Not Applicable

Which Markers of Musculoskeletal Health Can Explain Complications in Spinal Surgery?

Recruiting
NCT06535451

Lung Cancer Screening Program in Mexico

Recruiting
NCT04647409Not Applicable

Screening for NAFLD in Flanders

Active Not Recruiting
NCT07235332

Assessing Toxic Metal Exposure From Vegetarian/Vegan, Omnivorous, and Low-carb Diets in Israel.

Enrolling By Invitation
NCT07225374Phase 2

Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

Recruiting
NCT06887569Not Applicable

Using Financial Incentives and Screening to Increase Engagement With Mental Health Services Among College Students in Chennai, India

Completed
NCT05844033

Biomarker for Infection Risk in CLL and MM

Active Not Recruiting
NCT04999982Not Applicable

Pilot Testing PREschooler Care, Community Resources, Advocacy, Referral, Education (PRE-CARE)

Completed
NCT02956031

Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.

Recruiting
NCT04965792

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

Active Not Recruiting
NCT06439901Not Applicable

Optimizing Bronchopulmonary Cancer Screening

Recruiting
NCT04540484

COVID-19 IgG Formation in Physicians at ALGH and Their Household Members

Completed
NCT03852953

Under- and Overdiagnosis in BreastScreen Norway

Completed
NCT06557915

Nasal Problems in Neonates and Infants Subjected to CPAP

Not Yet Recruiting
NCT06345625

Gait and Postural Balance Analysis During Head-motion Perturbed Standing and Walking in Older Adults

Recruiting
NCT05760469Not Applicable

Seeing Red: Clinical Assessment Tools for Clinical Trial Decision Support

Not Yet Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
57